DUBLIN--(BUSINESS WIRE)--The "Global Prostate Cancer Market Growth, Trends & Forecasts 2017 - 2022" report has been added to Research and Markets' offering.
The Global Prostate Cancer Market is expected to reach $72 billion by the end of 2020 growing at a CAGR of around 9.7% from 2014 to 2021.
Prostate cancer is an advancement of cancer in the prostate, a gland present in the male reproductive system which exists directly under the bladder in front of the rectum. The cancer cells may spread from the prostate to the other parts of the body, viz. the bones and lymph nodes. In the later stages of cancer it can cause difficulty in urination, blood in the urine, etc. Old age, family history and race are some of the factors that increase the risk of prostate cancer. Prostate cancer is most of the times diagnosed by biopsy.
Change in lifestyle, technological advancements in finding new techniques to fight prostate cancer, rise in the funding in both public and private sector in the field of drug development are some of the reasons driving the growth of the market.
High cost of treatment, side effects of surgery like urinary incontinence & impotence and surgical risks like heart attack, stroke, blood clots etc. are some of the constraints faced by the market.
- GE Healthcare
- Seimens Healthcare
- Johnson & Johnson
Key Topics Covered:
2. Executive Summary
3. Market Overview
4. Porters Five Force Analysis
5. Market Segmentation
6. Competitive Landscape
7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/hmsfr4/global_prostate